Description
PharmaQo Clomid 50 delivers 50 mg Clomiphene Citrate per oral tablet, packaged in 50-tablet packs for research use. Clomiphene is widely studied as a selective estrogen receptor modulator (SERM), particularly for its effects on stimulating gonadotropin release, inducing ovulation, and supporting post-cycle hormone recovery in investigational settings.
It works by blocking estrogen receptors in the hypothalamus, stimulating the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) — crucial in reproductive and hormonal studies.
Product Details:
Active Ingredient:
-
Clomiphene Citrate (Clomid)
Concentration: 50 mg per tablet
Form: Oral tablets
Packaging: 50 tablets per pack
Pharmacokinetics:
Clomiphene has a long half-life (~5–7 days), allowing for effective modulation of estrogen feedback over extended periods.
Usage Recommendations:
-
Indications (Research Context): Investigational use in ovulation induction, male hormone recovery models, fertility studies (not approved for human use)
-
Typical Dosage (Research Use): 25–100 mg per day, depending on study
-
Monitoring: Hormone panels, ovarian/follicular response, testicular function, liver function
-
Cycle/Duration: 4–6 weeks per research protocol
Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human consumption or therapeutic use. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with medical risks. Always adhere to local research regulations and ethical standards.